Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

855 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Calcium channel blocker and Rho-associated kinase activity in patients with hypertension.
Hata T, Soga J, Hidaka T, Idei N, Fujii Y, Fujimura N, Mikami S, Maruhashi T, Kihara Y, Chayama K, Kato H, Noma K, Liao JK, Higashi Y; ROCK Study Group. Hata T, et al. Among authors: kihara y. J Hypertens. 2011 Feb;29(2):373-9. doi: 10.1097/HJH.0b013e328340902d. J Hypertens. 2011. PMID: 21063203 Free PMC article. Clinical Trial.
Mineralocorticoid receptor blocker eplerenone improves endothelial function and inhibits Rho-associated kinase activity in patients with hypertension.
Fujimura N, Noma K, Hata T, Soga J, Hidaka T, Idei N, Fujii Y, Mikami S, Maruhashi T, Iwamoto Y, Kihara Y, Chayama K, Kato H, Liao JK, Higashi Y; ROCK Study Group. Fujimura N, et al. Among authors: kihara y. Clin Pharmacol Ther. 2012 Feb;91(2):289-97. doi: 10.1038/clpt.2011.227. Epub 2011 Dec 28. Clin Pharmacol Ther. 2012. PMID: 22205191 Free PMC article. Clinical Trial.
Rho-associated kinase activity is a predictor of cardiovascular outcomes.
Kajikawa M, Noma K, Maruhashi T, Mikami S, Iwamoto Y, Iwamoto A, Matsumoto T, Hidaka T, Kihara Y, Chayama K, Nakashima A, Goto C, Liao JK, Higashi Y. Kajikawa M, et al. Among authors: kihara y. Hypertension. 2014 Apr;63(4):856-64. doi: 10.1161/HYPERTENSIONAHA.113.02296. Epub 2013 Dec 30. Hypertension. 2014. PMID: 24379190 Free PMC article.
Effect of aldosterone-producing adenoma on endothelial function and Rho-associated kinase activity in patients with primary aldosteronism.
Matsumoto T, Oki K, Kajikawa M, Nakashima A, Maruhashi T, Iwamoto Y, Iwamoto A, Oda N, Hidaka T, Kihara Y, Kohno N, Chayama K, Goto C, Aibara Y, Noma K, Liao JK, Higashi Y. Matsumoto T, et al. Among authors: kihara y. Hypertension. 2015 Apr;65(4):841-8. doi: 10.1161/HYPERTENSIONAHA.114.05001. Epub 2015 Jan 26. Hypertension. 2015. PMID: 25624340 Free PMC article.
Rho-associated kinase activity is an independent predictor of cardiovascular events in acute coronary syndrome.
Kajikawa M, Noma K, Nakashima A, Maruhashi T, Iwamoto Y, Matsumoto T, Iwamoto A, Oda N, Hidaka T, Kihara Y, Aibara Y, Chayama K, Sasaki S, Kato M, Dote K, Goto C, Liao JK, Higashi Y. Kajikawa M, et al. Among authors: kihara y. Hypertension. 2015 Oct;66(4):892-9. doi: 10.1161/HYPERTENSIONAHA.115.05587. Epub 2015 Aug 17. Hypertension. 2015. PMID: 26283039 Free PMC article.
Endothelial Function Is Impaired in Patients Receiving Antihypertensive Drug Treatment Regardless of Blood Pressure Level: FMD-J Study (Flow-Mediated Dilation Japan).
Maruhashi T, Soga J, Fujimura N, Idei N, Mikami S, Iwamoto Y, Iwamoto A, Kajikawa M, Matsumoto T, Oda N, Kishimoto S, Matsui S, Hashimoto H, Aibara Y, Yusoff FBM, Hidaka T, Kihara Y, Chayama K, Noma K, Nakashima A, Goto C, Tomiyama H, Takase B, Kohro T, Suzuki T, Ishizu T, Ueda S, Yamazaki T, Furumoto T, Kario K, Inoue T, Koba S, Watanabe K, Takemoto Y, Hano T, Sata M, Ishibashi Y, Node K, Maemura K, Ohya Y, Furukawa T, Ito H, Ikeda H, Yamashina A, Higashi Y. Maruhashi T, et al. Among authors: kihara y. Hypertension. 2017 Oct;70(4):790-797. doi: 10.1161/HYPERTENSIONAHA.117.09612. Epub 2017 Aug 14. Hypertension. 2017. PMID: 28808069 Clinical Trial.
Eplerenone improves endothelial function and arterial stiffness and inhibits Rho-associated kinase activity in patients with idiopathic hyperaldosteronism: a pilot study.
Kishimoto S, Oki K, Maruhashi T, Kajikawa M, Matsui S, Hashimoto H, Takaeko Y, Kihara Y, Chayama K, Goto C, Aibara Y, Yusoff FM, Nakashima A, Noma K, Liao JK, Higashi Y. Kishimoto S, et al. Among authors: kihara y. J Hypertens. 2019 May;37(5):1083-1095. doi: 10.1097/HJH.0000000000001989. J Hypertens. 2019. PMID: 30418321 Free PMC article.
855 results